Initial Statement of Beneficial Ownership (3)
01 February 2022 - 8:45AM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
|
1. Name and Address of Reporting Person
*
Feinstein Darin |
2. Date of Event Requiring Statement (MM/DD/YYYY)
1/19/2022
|
3. Issuer Name and Ticker or Trading Symbol
Core Scientific, Inc./tx [CORZ]
|
|
(Last)
(First)
(Middle)
C/O CORE SCIENTIFIC, INC., 106 EAST 6TH STREET, SUITE 900-145 |
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
__X__ Director ___X___ 10% Owner
___X___ Officer (give title below) _____ Other (specify below)
Chief Vision Officer / |
|
(Street)
AUSTIN, TX 78701
(City)
(State)
(Zip)
| 5. If Amendment, Date Original Filed(MM/DD/YYYY)
| 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security
(Instr. 4) | 2. Amount of Securities Beneficially Owned
(Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) | 4. Nature of Indirect Beneficial Ownership
(Instr. 5) |
| Common Stock | 35991574 | D | |
| Common Stock | 811918 | I | See footnote (1) |
| Common Stock | 974301 | I | See footnote (2) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 4) | 2. Date Exercisable and Expiration Date
(MM/DD/YYYY) | 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) | 6. Nature of Indirect Beneficial Ownership
(Instr. 5) |
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
| Stock Option (right to buy) | (3) | 10/9/2028 | Common Stock | 1600153 | $7.02 | D | |
| Stock Option (right to buy) | (4) | 1/2/2031 | Common Stock | 202979 | $2.77 | D | |
| Stock Option (right to buy) | (4) | 1/2/2031 | Common Stock | 1014897 | $2.77 | D | |
| Stock Option (right to buy) | (5) | 1/18/2032 | Common Stock | 8000764 | $10.15 | D | |
| Explanation of Responses: |
| (1) | The shares are held by Red Moon 88, LLC, which the Reporting Person serves as its managing member. |
| (2) | The shares are held by Texas Blockchain 888, LLC, which the Reporting Person serves as its managing member. |
| (3) | Twenty-five percent (25%) of the shares subject to the option vested on October 3, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person's continued service through each such date. |
| (4) | Immediately exercisable. |
| (5) | Twenty-five percent (25%) of the shares subject to the option shall vest in equal annual installments commencing January 18, 2023, subject to Reporting Person's continued service through each such date. |
Remarks:
Exhibit List - Exhibit 24 - Power of Attorney |
Reporting Owners
|
| Reporting Owner Name / Address | Relationships |
| Director | 10% Owner | Officer | Other |
Feinstein Darin
C/O CORE SCIENTIFIC, INC.
106 EAST 6TH STREET, SUITE 900-145
AUSTIN, TX 78701 | X | X | Chief Vision Officer |
|
Signatures
|
| /s/ Jason Minio, Attorney-in-Fact | | 1/31/2022 |
| **Signature of Reporting Person | Date |
Core Scientific (NASDAQ:CORZ)
Historical Stock Chart
From Mar 2024 to Apr 2024
Core Scientific (NASDAQ:CORZ)
Historical Stock Chart
From Apr 2023 to Apr 2024
